论文部分内容阅读
我院从1996年5月以来，应用康莱特注射液（浙江康莱特药业有限公司生产）治疗晚期消化道肿瘤30例。现将临床观察结果报告如下：1资料和方法1.1一般资料30例患者均为晚期消化道肿瘤住院患者，诊断符合《中国常见恶性肿瘤诊治规范》的制定标准。其中男性22例，女性8例，年龄38—7
Since May 1996, Kangluite Injection (produced by Zhejiang Kanglaite Pharmaceutical Co., Ltd.) has been used in 30 cases of advanced gastrointestinal cancer. The clinical observation results are reported as follows: 1 Materials and Methods 1.1 General Information 30 patients were hospitalized patients with advanced gastrointestinal cancer, diagnosis in line with the “common Chinese norms of diagnosis and treatment of malignant tumors,” the development of standards. Among them, there are 22 males and 8 females, aged 38-7.